The original can be found here.
Note from Max Davie: I have co-authored this post with my colleague Dr Lorna Hobbs. We have been dismayed at the uncritical way in which the deeply flawed Cass report has been accepted both professionally and in the wider political conversation. We wanted an alternative view, from experienced clinicians, to be out there in the public conversation. We have chosen to publish this on a blog, rather than in a journal or other publication, so that we can publish in a timely way and maximise access for people who might find our writing helpful.
The Cass review - the most comprehensive review of gender-related care for children and adolescents to date[1] - was published four months ago now, and its impact on the world of youth gender healthcare is becoming clearer, with the review findings already being used to justify a legal ban on any new puberty-pausing prescriptions for gender diverse young people, under 18, in England, Scotland and Wales (outside of a research protocol); and further afield, in the US, it is being used in at least ten states to support legal bans on gender-affirming care for young people (McNamara et al., 2024[2]). At the same time, a new UK government is taking office, with an opportunity to take their own perspective on the document.